Title: Sjögren’s Patients Could Benefit from Lupus Drug
Abstract: B-cells that are active in lupus may also play a role in Sjogren’s syndrome. A new study finds that the same B-cell depleter drug, belimumab (Benlysta) approved for lupus, may also benefit Sjogren’s patients.
Publication Year: 2015
Publication Date: 2015-08-20
Language: en
Type: article
Access and Citation
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot